Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Scott E et al. – FFP, FP24, and the derived TP all contain adequate coagulation factor activities to maintain hemostatic activity. As FFP becomes less available, increased use of FP24 and TP are viable alternatives for most clinical situations.

Related Articles

Update on the use of deferasirox in the management of iron overload
Therapeutics and Clinical Risk Management, 11/05/09    Relevance Score: 67%

Transfusion therapy in hemorrhagic shock
Current Opinion in Critical Care, 11/10/09    Relevance Score: 66%

Massive transfusion – evaluation of current clinical practice and outcome in two large teaching hospital trusts in Northern England
Vox Sanguinis, 10/06/09    Relevance Score: 66%

The use of cord blood for transfusion purposes: current status
Vox Sanguinis, 10/15/09    Relevance Score: 65%

Temporary Drainage Clamping After Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials
Journal of Arthroplasty, 10/21/09    Relevance Score: 64%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address